Addus HomeCare (NASDAQ:ADUS) Upgraded at Truist Financial

Addus HomeCare (NASDAQ:ADUS) was upgraded by equities research analysts at Truist Financial to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports.

Several other equities analysts have also recently weighed in on the company. BMO Capital Markets initiated coverage on Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective on the stock. Royal Bank Of Canada increased their target price on shares of Addus HomeCare from $134.00 to $139.00 and gave the company an “outperform” rating in a report on Friday, November 7th. Barclays raised their price target on shares of Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research report on Tuesday, November 4th. TD Cowen upped their price objective on shares of Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Finally, Cowen reiterated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and an average price target of $136.90.

Addus HomeCare Price Performance

ADUS stock opened at $112.33 on Wednesday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.66 and a current ratio of 1.66. The business has a 50-day simple moving average of $113.26 and a two-hundred day simple moving average of $113.44. The company has a market capitalization of $2.08 billion, a P/E ratio of 24.05, a price-to-earnings-growth ratio of 1.35 and a beta of 0.92. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last issued its quarterly earnings data on Monday, November 3rd. The company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.53 by $0.03. The firm had revenue of $362.30 million during the quarter, compared to the consensus estimate of $354.48 million. Addus HomeCare had a return on equity of 9.53% and a net margin of 6.36%.The company’s quarterly revenue was up 25.0% compared to the same quarter last year. During the same period in the prior year, the business posted $1.30 earnings per share. Research analysts expect that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling

In other Addus HomeCare news, EVP Darby Anderson sold 20,000 shares of Addus HomeCare stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $109.00, for a total value of $2,180,000.00. Following the sale, the executive vice president owned 44,144 shares of the company’s stock, valued at approximately $4,811,696. The trade was a 31.18% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders have sold a total of 20,316 shares of company stock valued at $2,215,998 over the last 90 days. Insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC purchased a new position in Addus HomeCare in the fourth quarter valued at approximately $207,000. Nordea Investment Management AB increased its position in Addus HomeCare by 8.1% in the fourth quarter. Nordea Investment Management AB now owns 40,430 shares of the company’s stock worth $4,345,000 after buying an additional 3,032 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Addus HomeCare by 17.3% in the fourth quarter. GAMMA Investing LLC now owns 2,086 shares of the company’s stock valued at $224,000 after buying an additional 308 shares during the period. CIBC Bancorp USA Inc. purchased a new position in shares of Addus HomeCare during the 3rd quarter valued at $228,000. Finally, Danske Bank A S purchased a new position in shares of Addus HomeCare during the 3rd quarter valued at $883,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.